Diagnos Laboratorium Utama PT Tbk Capital Reinvestment Ratio
Diagnos Laboratorium Utama PT Tbk capital reinvestment ratio. Diagnos Laboratorium Utama PT Tbk (DGNS) has a Capital Reinvestment Ratio of 1.74x as of June 2025, meaning it reinvests 2% of its operating cash flow (Rp1.52 Billion) in capital expenditures (Rp2.64 Billion). See DGNS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Diagnos Laboratorium Utama PT Tbk (2018–2024)
Capital reinvestment ratio of Diagnos Laboratorium Utama PT Tbk from 2018 to 2024. This chart tracks Diagnos Laboratorium Utama PT Tbk's Capital Reinvestment Ratio across 6 annual periods. See financial flexibility index of Diagnos Laboratorium Utama PT Tbk to measure the company's free cash flow as a share of total liabilities.
Diagnos Laboratorium Utama PT Tbk Capital Reinvestment Ratio by Year (2018–2024)
Diagnos Laboratorium Utama PT Tbk capital reinvestment ratio by year from 2018 to 2024. For the full cash flow conversion analysis, see Diagnos Laboratorium Utama PT Tbk cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.59x | Rp27.30 Billion | Rp43.39 Billion | ▼ -45.3% |
| 2023 | 2.91x | Rp13.18 Billion | Rp38.32 Billion | ▲ +152.3% |
| 2021 | 1.15x | Rp58.87 Billion | Rp67.84 Billion | ▲ +415.4% |
| 2020 | 0.22x | Rp26.23 Billion | Rp5.86 Billion | ▼ -10.0% |
| 2019 | 0.25x | Rp11.20 Billion | Rp2.78 Billion | ▼ -45.2% |
| 2018 | 0.45x | Rp8.47 Billion | Rp3.84 Billion | — |